FCE
Fiera Capital (Europe) Portfolio holdings
AUM $213M
1-Year Return
42.4%
This Quarter Return
-3.02%
1 Year Return
+42.4%
3 Year Return
+41.22%
5 Year Return
–
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(+80,907%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
18.8%
Top 10 Holdings %
Top 10 Hldgs %
77.06%
Holding
61
New
11
Increased
20
Reduced
16
Closed
13
Top Buys
| 1 |
Baidu
BIDU
|
+$21.6M |
| 2 |
Itaú Unibanco
ITUB
|
+$15.3M |
| 3 |
JD.com
JD
|
+$6.88M |
| 4 |
Ambev
ABEV
|
+$6.41M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$6.26M |
Top Sells
| 1 |
Stryker
SYK
|
+$15.6M |
| 2 |
Gilead Sciences
GILD
|
+$14.6M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
CELG
Celgene Corp
CELG
|
+$11.7M |
| 5 |
Credicorp
BAP
|
+$5.2M |
Sector Composition
| 1 | Financials | 25.32% |
| 2 | Communication Services | 24.92% |
| 3 | Consumer Staples | 20.6% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Healthcare | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CZZ
26
DELISTED
Cosan Limited
CZZ
| $305K | 0.28% |
47,798
+20,525
| +75% | +$131K |
|
|
LCI
27
DELISTED
Lannett Company, Inc.
LCI
| $278K | 0.25% |
+1,021
| New | +$278K |
|
|
28
Thermo Fisher Scientific
TMO
$179B
| $272K | 0.25% |
2,020
-87,602
| -98% | -$11.8M |
|
29
Amgen
AMGN
$148B
| $261K | 0.24% |
1,633
-6,818
| -81% | -$1.09M |
|
|
AEGR
30
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $252K | 0.23% |
9,641
| – | – |
|
31
Bristol-Myers Squibb
BMY
$94.3B
| $240K | 0.22% |
3,710
+1,954
| +111% | +$126K |
|
32
Vale
VALE
$46.6B
| $217K | 0.2% |
+38,411
| New | +$217K |
|
33
CVS Health
CVS
$93.2B
| $214K | 0.19% |
+2,068
| New | +$214K |
|
|
MDVN
34
DELISTED
MEDIVATION, INC.
MDVN
| $208K | 0.19% |
3,210
-11,514
| -78% | -$746K |
|
|
IPXL
35
DELISTED
Impax Laboratories, Inc.
IPXL
| $185K | 0.17% |
3,949
+2,523
| +177% | +$118K |
|
36
Illumina
ILMN
$15.5B
| $176K | 0.16% |
975
-1,970
| -67% | -$356K |
|
37
Regeneron Pharmaceuticals
REGN
$60.7B
| $155K | 0.14% |
341
-1,228
| -78% | -$558K |
|
38
Becton Dickinson
BDX
$53.4B
| $151K | 0.14% |
1,076
+834
| +345% | +$117K |
|
39
Boston Scientific
BSX
$147B
| $136K | 0.12% |
+7,675
| New | +$136K |
|
40
Amphastar Pharmaceuticals
AMPH
$1.27B
| $126K | 0.11% |
8,451
-113,125
| -93% | -$1.69M |
|
41
Abbott
ABT
$229B
| $109K | 0.1% |
2,339
-2,771
| -54% | -$129K |
|
|
CELG
42
DELISTED
Celgene Corp
CELG
| $105K | 0.1% |
908
-100,874
| -99% | -$11.7M |
|
|
43
Stryker
SYK
$144B
| $97K | 0.09% |
1,047
-168,215
| -99% | -$15.6M |
|
44
Edwards Lifesciences
EW
$44.6B
| $93K | 0.08% |
+3,924
| New | +$93K |
|
45
Biogen
BIIB
$21.1B
| $92K | 0.08% |
216
-448
| -67% | -$191K |
|
46
Cardinal Health
CAH
$35.9B
| $89K | 0.08% |
+981
| New | +$89K |
|
47
Incyte
INCY
$16.2B
| $79K | 0.07% |
857
-4,011
| -82% | -$370K |
|
48
IQVIA
IQV
$31.6B
| $65K | 0.06% |
973
+632
| +185% | +$42.2K |
|
49
AbbVie
ABBV
$382B
| – | – |
-5,332
| Closed | -$349 |
|
50
BioMarin Pharmaceuticals
BMRN
$10.2B
| – | – |
-515,289
| Closed | -$6.93K |
|